Brexit /consequences for operators

Name: Brexit /consequences for operators
Creator: National Agency for the Safety of Medicines and Health Products
Keywords: applications,authorization,brexit,clinical-trials,human-medicinal-products,market-authorization,marketing,marketing-authorization,markets,medicinal-products,notices,procedures,sponsors

Information

Original link

Type

Reference Document

Regulated products

Medical Devices

Published

April 16, 2021

Last updated

May 25, 2021

Description

Brexit reference document /consequences for the operators in your application process

Organization

National Agency for the Safety of Medicines and Health Products (ANSM) 🇫🇷

Country / Region

France

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

7 Main files

"Brexit" - Avis aux titulaires d’AMM de médicaments à usage humain (16/04/2021)

Updated on April 16, 2021

pdf

URL: https://ansm.sante.fr/uploads/2021/04/16/202010158-brexit-avis-titulaires-septembre.pdf
Permalink: https://data.openrid.co/en/datasets/r/e0e1c068-3eb1-4058-a166-5cf5149f67eb
MIME Type: application/pdf

Created on: April 16, 2021
Modified on: April 16, 2021

"Brexit "- Notice to Marketing Authorization HoldersFor Human medicinal products registered via Mutual recognition, decentralized or purely national procedures (16/04/2021)

Updated on April 16, 2021

pdf

URL: https://ansm.sante.fr/uploads/2021/04/16/202010158-brexit-avis-titulaires-septembre-2.pdf
Permalink: https://data.openrid.co/en/datasets/r/aef2aeb6-6014-4392-a416-6778907706e8
MIME Type: application/pdf

Created on: April 16, 2021
Modified on: April 16, 2021

"Brexit" Avis aux promoteurs d'essais cliniques (16/04/2021)

Updated on April 16, 2021

pdf

URL: https://ansm.sante.fr/uploads/2021/04/16/20201015-brexit-avis-promoteurs-ec.pdf
Permalink: https://data.openrid.co/en/datasets/r/ebccf036-0906-42c4-ae24-b2849a98eb1d
MIME Type: application/pdf

Created on: April 16, 2021
Modified on: April 16, 2021

"Brexit" Notice to clinical trials sponsors (16/04/2021)

Updated on April 16, 2021

pdf

URL: https://ansm.sante.fr/uploads/2021/04/16/20201015-brexit-notice-clinical-trials-sponsors-oct-2020.pdf
Permalink: https://data.openrid.co/en/datasets/r/f1f06dcf-cedc-4d57-ba6b-06f98144c842
MIME Type: application/pdf

Created on: April 16, 2021
Modified on: April 16, 2021

"Brexit" Recommandation aux promoteurs d’essais cliniques de médicaments (16/04/2021)

Updated on April 16, 2021

pdf

URL: https://ansm.sante.fr/uploads/2021/04/16/20201015-brexit-recommandation-ec-med-oct-2020.pdf
Permalink: https://data.openrid.co/en/datasets/r/560475b0-a948-407b-8231-427edf542d79
MIME Type: application/pdf

Created on: April 16, 2021
Modified on: April 16, 2021

"Brexit" - Recommandation aux promoteurs d’essais cliniques autres que ceux portant sur le médicament (16/04/2021)

Updated on April 16, 2021

pdf

URL: https://ansm.sante.fr/uploads/2021/04/16/20201015-brexit-recommandation-ec-autres-que-med.pdf
Permalink: https://data.openrid.co/en/datasets/r/02391948-c8de-48db-a845-cf84e811139f
MIME Type: application/pdf

Created on: April 16, 2021
Modified on: April 16, 2021

See the 7 main files

Brexit /consequences for operators

Information

Type

Regulated products

Published

Last updated

Description

Tags

Organization

Country / Region

License

Feedback

Actions

Social networks

Embed